首都医科大学附属北京天坛医院，是首都医科大学附属的一所以神经科为重点的三级甲等综合医院。

During the past decade, Beijing Tiantan Hospital conducted 265 clinical trials. In the 10-year time frame, 265 clinical trials started and 8 clinical trials were completed, i.e. on average, 3% percent of trials that started reached the finish line to date. In the past 5 years, 168 clinical trials started and 6 clinical trials were completed. i.e. 3.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Tiantan Hospital" #1 sponsor was "Beijing Tiantan Hospital" with 132 trials, followed by "Beijing Neurosurgical Institute" with 10 trials sponsored, "Ministry of Science and Technology of the People´s Republic of China" with 10 trials sponsored, "Capital Medical University" with 9 trials sponsored and "Beijing Pins Medical Co., Ltd" with 9 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Tiantan Hospital" #1 collaborator was "Beijing Tiantan Hospital" with 34 trials as a collaborator, "Peking Union Medical College Hospital" with 12 trials as a collaborator, "Peking University People's Hospital" with 7 trials as a collaborator, "Beijing Ditan Hospital" with 6 trials as a collaborator and "Beijing Municipal Science & Technology Commission" with 6 trials as a collaborator. Other collaborators include 336 different institutions and companies that were collaborators in the rest 217 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Tiantan Hospital" are "Stroke" (20 trials), "Acute Ischemic Stroke" (18 trials), "Ischemic Stroke" (16 trials), "Glioma" (9 trials) and "Intracranial Aneurysm" (8 trials). Many other conditions were trialed in "Beijing Tiantan Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Tiantan Hospital" are "Drug" (159 trials), "Device" (36 trials), "Procedure" (35 trials), "Other" (30 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Dexmedetomidine" (11 trials), "Propofol" (5 trials), "Saline" (5 trials) and "Temozolomide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Tiantan Hospital" are 288 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 138 active trials in "Beijing Tiantan Hospital". 14 are not yet recruiting, 105 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Beijing Tiantan Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Tiantan Hospital, 19 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 33 trials, and there were also 94 trials that are defined as “Not Applicable".

Beijing Tiantan Hospital has several departments that took part in Clinical trials: "Department of Anesthesiology,Beijing Tiantan Hospital, Capital Medical University" - 5 trials, "Beijing Neurosurgical Institute" - 2 trials